The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease
Abstract
BACKGROUND: Patients with mild or moderate chronic obstructive pulmonary disease (COPD) rarely receive medications, because they have few symptoms. We hypothesized that long-term use of tiotropium would improve lung function and ameliorate the decline in lung function in patients with mild or moderate COPD. METHODS: before and after bronchodilator use from day 30 to month 24. RESULTS: after bronchodilator use was significantly less in the tiotropium group than in the placebo group (29±5 ml per year vs. 51±6 ml per year; difference, 22 ml per year [95% CI, 6 to 37]; P=0.006). The incidence of adverse events was generally similar in the two groups. CONCLUSIONS: after bronchodilator use in patients with COPD of GOLD stage 1 or 2. (Funded by Boehringer Ingelheim and others; Tie-COPD ClinicalTrials.gov number, NCT01455129 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
(1993) · PubMed · Cited by 3,827
Development and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,366
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
Yang, G., Wang, Y., Zeng, Y., Gao, G. F., Liang, X., Zhou, M., Wan, X., Yu, S., Jiang, Y., Naghavi, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61097-1 · Cited by 1,982
Self-citationA 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Guan, W.-J., Zheng, X.-Y., Chung, K. F., & Zhong, N.-S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31597-5 · Cited by 902
Self-citationDevelopment, validity and responsiveness of the Clinical COPD Questionnaire.
van der Molen, T., Willemse, B. W. M., Schokker, S., ten Hacken, N. H. T., Postma, D. S., & Juniper, E. F. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-13 · Cited by 733
Prevalence of Chronic Obstructive Pulmonary Disease in China: A Large, Population-based Survey
Zhong, N., Wang, C., Yao, W., Chen, P., Kang, J., Huang, S., Chen, B., Wang, C., Ni, D., Zhou, Y., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1749oc · Cited by 729
Self-citationTiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
Decramer, M., Celli, B., Kesten, S., Lystig, T., Mehra, S., & Tashkin, D. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61298-8 · Cited by 495
Bhatt, S. P., Soler, X., Wang, X., Murray, S., Anzueto, A. R., Beaty, T. H., Boriek, A. M., Casaburi, R., Criner, G. J., Diaz, A. A., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2219oc · Cited by 386
Tantucci, C., & Modina, D. (2012) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s27480 · Cited by 321
Zhou, Y., Zou, Y., Li, X., Chen, S., Zhao, Z., He, F., Zou, W., Luo, Q., Li, W., Pan, Y., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001621 · Cited by 206
Self-citationCOPD: early diagnosis and treatment to slow disease progression
Welte, T., Vogelmeier, C. F., & Papi, A. A. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12522 · Cited by 141
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT® trial
Troosters, T., Celli, B. R., Lystig, T., Kesten, S., Mehra, S., Tashkin, D. P., & Decramer, M. (2010) · European Respiratory Journal · doi:10.1183/09031936.00127809 · Cited by 134
Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD
Johansson, G. S., Lindberg, A., Romberg, K., Nordström, L., Gerken, F., & Roquetd, A. (2008) · Primary Care Respiratory Journal · doi:10.3132/pcrj.2008.00037 · Cited by 63
Efficacy of Tiotropium in COPD Patients with FEV1 ≥ 60% Participating in the UPLIFT® Trial
Tashkin, D. P., Celli, B. R., Decramer, M., Lystig, T., Liu, D., & Kesten, S. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.656211 · Cited by 50
Yoo, C., Lee, H. Y., Choi, S. M., Lee, J., Park, Y. S., Lee, C.-H., Kim, D. K., Lee, S. M., Yim, J., Kim, Y. W., et al. (2015) · International Journal of COPD · doi:10.2147/copd.s91901 · Cited by 5
Cited by
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00239-2023 · Cited by 1,303
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Agustí, A., Celli, B. R., Criner, G. J., Halpin, D., Anzueto, A., Barnes, P., Bourbeau, J., Han, M. K., Martinez, F. J., Montes de Oca, M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0106pp · Cited by 827
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
Fang, L., Gao, P., Bao, H., Tang, X., Wang, B., Feng, Y., Cong, S., Juan, J., Fan, J., Lu, K., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30103-6 · Cited by 467
At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease
Martinez, F. J., Han, M. K., Allinson, J. P., Barr, R. G., Boucher, R. C., Calverley, P. M. A., Celli, B. R., Christenson, S. A., Crystal, R. G., Fagerås, M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2028pp · Cited by 282
Metadata
- Authors
- Zhou, Y., Zhong, N.-S., Li, X., Chen, S., Zheng, J., Zhao, D., Yao, W., Zhi, R., Wei, L., He, B., Zhang, X., Yang, C., Li, Y., Li, F., Du, J., Gui, J., Hu, B., Bai, C., Huang, P., Chen, G., Xu, Y., Wang, C., Liang, B., Li, Y., Hu, G., Tan, H., Ye, X., Ma, X., Chen, Y., Hu, X., Tian, J., Zhu, X., Shi, Z., Du, X., Li, M., Liu, S., Yu, R., Zhao, J., Ma, Q., Xie, C., Li, X., Chen, T., Lin, Y., Zeng, L., Ye, C., Ye, W., Luo, X., Zeng, L., Yu, S., Guan, W.-J., & Ran, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-09-07
- Volume
- 377
- Issue
- 10
- Pages
- 923-935
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2753810958
- Cited by
- 282
- References
- 23
- FWCI
- 23.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.